Rafaxone TZ 500mg/62.5mg Injection
Marketer
Aarcin Pharmaceutical LLP
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Rafaxone TZ 500mg/62.5mg Injection
Combiflox TZ, a 500mg/62.5mg injectable formulation, combats diverse bacterial infections. Its dual-action mechanism inhibits microbial proliferation and halts infection spread. Administration must be overseen by a physician. Complete the prescribed regimen, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions warrant immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require emergency care. Disclose all current medications to your doctor prior to use. Consult your physician if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving is discouraged if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are vital for optimal recovery. Follow-up laboratory assessments may be conducted to monitor therapeutic response.
Uses of Rafaxone TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Rafaxone TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rafaxone TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Rafaxone TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Rafaxone TZ 500mg/62.5mg Injection works:
The injectable formulation Rafaxone TZ (500mg/62.5mg) unites ceftriaxone, a bacterium-fighting antibiotic, with tazobactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Tazobactam's role is to counteract bacterial resistance mechanisms, thereby boosting ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
No adverse reactions are associated with the concomitant use of alcohol and Rafaxone TZ 500mg/62.5mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Rafaxone TZ (500mg/62.5mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Rafaxone TZ 500mg/62.5mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Rafaxone TZ 500mg/62.5mg Injection could induce drowsiness, visual disturbances, and dizziness. Driving is inadvisable if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rafaxone TZ 500mg/62.5mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Exercise caution when administering Rafaxone TZ 500mg/62.5mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alterations for Rafaxone TZ 500mg/62.5mg Injection are unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Rafaxone TZ 500mg/62.5mg Injection :
Should you forget a scheduled dose of Rafaxone TZ 500mg/62.5mg Injection, seek advice from your physician.
Facts to Know About Rafaxone TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently